Delivery Order SPE2DX22D0029-SPE2D826F05CE
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $11,161.84 by the Defense Logistics Agency's Medical Supply Chain on October 29, 2025, with an ultimate completion date of October 30, 2025. This is a firm fixed-price, non-set-aside contract with performance at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $32,624.82 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, with an ultimate completion date of June 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The work will be...
- AmerisourceBergen Drug Corp was awarded a $20,793.86 firm fixed price delivery order by the Defense Logistics Agency's Medical Supply Chain on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $23,237.52 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $22,542.24 by the Defense Logistics Agency's Medical Supply Chain on November 3, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by November 4, 2025. The award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,791.72 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, which is not set-aside and was competitively awarded, is scheduled for ultimate completion on August 26, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $1,410.74 by the Defense Logistics Agency's Medical Supply Chain on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a potential value of $999,999,999.00 through December 2026. The delivery order will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,514.52 on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, with an ultimate completion date of August 29, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,156.19 on October 20, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of October 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $32,346.54 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025. This non-set-aside contract (Contract Number 4569060760) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F05CEDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $32,142.24 by the Defense Logistics Agency's Medical Supply Chain on November 8, 2025, with a completion deadline of November 10, 2025. This is a firm fixed-price, non-set-aside competitive award to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, a prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order falls within the company's broader role supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through DLA's global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.1k | 11/8/25 |